Differential cytotoxicity of trace metals in cisplatin-sensitive and -resistant human ovarian cancer cells

被引:0
|
作者
Daniel L Nicholson
Susan M Purser
Robert H Maier
机构
[1] East Carolina University,Department of Surgery, Trace Element Center
来源
Biometals | 1998年 / 11卷
关键词
cisplatin; ctyotoxicity; metals; ovarian cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular resistance of cisplatin is related to variousfactors such as membrane transformations, changes incellular transport systems, andan increased efflux of cisplatin by the tumor cells. Deficiencies of one ormoretrace metals can affect normal physiological functions, leading to altered enzymaticactivities and areduction in immune responses. This in vitro investigation was undertaken tostudy and determine the differ-entialcytotoxicity of certain trace metals in humanovarian cancer cells that were sensitive and resistant tocisplatin. Standardcytotoxicity assays were performed using the neutral red assay. In general, thecisplatin-resistantcells exhibited an increased resistance to the externally supplied trace metals. For bothcell linesthe rank order of cytotoxicity from greatest to least with the non-essentialmetals was Cd >Bi , and forthe macrometals, Ca >K + >Mg . The transition metals and selenium exhibited a slight difference betweenthe two celllines with respect to the order of cytotoxicity. The cisplatin-sensitive cells had a rankorder ofV >Se >Cu >Zn >Fe , from greatest to least toxicity. The cisplatin-resistant cells had a rank orderof Cu >V >Se >Zn >Fe . Since trace metals have various functions in maintaining normal health,these results provide key baselinecytotoxicity data and show that, in general, cytotoxic resistance to thetrace metals testedfollowed a pattern similar to cellular cisplatin resistance.
引用
收藏
页码:259 / 263
页数:4
相关论文
共 50 条
  • [31] Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation
    D. E. Wilkins
    C. E. Ng
    G. P. Raaphorst
    [J]. Cancer Chemotherapy and Pharmacology, 1997, 40 : 159 - 166
  • [32] Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation
    Wilkins, DE
    Ng, CE
    Raaphorst, GP
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (02) : 159 - 166
  • [33] RETRACTED: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer (Retracted Article)
    Wu, Wei
    Yu, Li-hua
    Ma, Bei
    Xu, Ming-juan
    [J]. PLOS ONE, 2014, 9 (03):
  • [34] Modulation of melphalan and cisplatin cytotoxicity in human ovarian cancer cells resistant to alkylating drugs
    Gornati, D
    Zaffaroni, N
    Villa, R
    DeMarco, C
    Silvestrini, R
    [J]. ANTI-CANCER DRUGS, 1997, 8 (05) : 509 - 516
  • [35] COMBINATION THERAPY WITH CISPLATIN AND NIFEDIPINE INDUCES APOPTOSIS IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN GLIOBLASTOMA CELLS
    KONDO, S
    YIN, D
    MORIMURA, T
    KUBO, H
    NAKATSU, S
    TAKEUCHI, J
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 282 - 289
  • [36] SELECTIVE POTENTIATION OF PLATINUM DRUG CYTOTOXICITY IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES BY AMPHOTERICIN-B
    SHARP, SY
    MISTRY, P
    VALENTI, MR
    BRYANT, AP
    KELLAND, LR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 35 (02) : 137 - 143
  • [37] Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells
    JVE Hettinga
    W Lemstra
    C Meijer
    WA Dam
    DRA Uges
    AWT Konings
    EGE De Vries
    HH Kampinga
    [J]. British Journal of Cancer, 1997, 75 : 1735 - 1743
  • [38] Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates
    Surowiak, P
    Materna, V
    Drag-Zalesinska, M
    Wojnar, A
    Kaplenko, I
    Spaczynski, M
    Dietel, M
    Zabel, M
    Lage, H
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2006, 25 (02) : 131 - 139
  • [39] Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells
    Hettinga, JVE
    Lemstra, W
    Meijer, C
    Los, G
    deVries, EGE
    Konings, AWT
    Kampinga, HH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (06) : 800 - 807
  • [40] Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells
    Hettinga, JVE
    Lemstra, W
    Meijer, C
    Dam, WA
    Uges, DRA
    Konings, AWT
    DeVries, EGE
    Kampinga, HH
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (12) : 1735 - 1743